HK1129063A1 - Tumor-targeted nanodelivery systems to improve early mri detection of cancer - Google Patents
Tumor-targeted nanodelivery systems to improve early mri detection of cancerInfo
- Publication number
- HK1129063A1 HK1129063A1 HK09106582.2A HK09106582A HK1129063A1 HK 1129063 A1 HK1129063 A1 HK 1129063A1 HK 09106582 A HK09106582 A HK 09106582A HK 1129063 A1 HK1129063 A1 HK 1129063A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tumor
- cancer
- improve early
- mri detection
- targeted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
- A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1234—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72830305P | 2005-10-20 | 2005-10-20 | |
PCT/US2006/041139 WO2007047981A2 (en) | 2005-10-20 | 2006-10-20 | Tumor-targeted nanodelivery systems to improve early mri detection of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1129063A1 true HK1129063A1 (en) | 2009-11-20 |
Family
ID=37963345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09106582.2A HK1129063A1 (en) | 2005-10-20 | 2009-07-20 | Tumor-targeted nanodelivery systems to improve early mri detection of cancer |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP5478886B2 (en) |
KR (1) | KR20080064169A (en) |
CN (1) | CN101351225B (en) |
AU (1) | AU2006304790B2 (en) |
CA (1) | CA2638899C (en) |
HK (1) | HK1129063A1 (en) |
IL (1) | IL190773A (en) |
WO (1) | WO2007047981A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101801344A (en) * | 2007-07-09 | 2010-08-11 | 乔治敦大学 | Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
US8320647B2 (en) | 2007-11-20 | 2012-11-27 | Olea Medical | Method and system for processing multiple series of biological images obtained from a patient |
CA3039251C (en) | 2008-11-10 | 2024-01-09 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
CN102078624B (en) * | 2010-12-23 | 2012-07-25 | 华东理工大学 | Efficient Gd-loaded liposome preparation and preparation method thereof |
WO2013031619A1 (en) * | 2011-08-26 | 2013-03-07 | 学校法人藤田学園 | Image-based tumor diagnosis agent containing anti-human transferrin receptor antibody |
US20140120157A1 (en) | 2012-09-19 | 2014-05-01 | Georgetown University | Targeted liposomes |
CA2806896C (en) * | 2012-09-19 | 2021-06-15 | Georgetown University | Targeted liposomes prepared by ethanol injection |
KR20150131263A (en) * | 2013-03-14 | 2015-11-24 | 조지타운 유니버시티 | Treatment for exposure to nerve agent |
EP3790533A1 (en) * | 2018-05-08 | 2021-03-17 | University of Florida Research Foundation, Incorporated | Magnetic liposomes and related treatment and imaging methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3902794B2 (en) * | 1997-03-07 | 2007-04-11 | マックス−デルブルック−セントラム フュア モレクラーレ メディシン | Specific magnetic material, its production method and use |
ATE511543T1 (en) * | 1999-02-22 | 2011-06-15 | Univ Georgetown | IMMUNOLIPOSOMES WITH A TARGETING ANTIBODY FRAGMENT FOR SYSTEMIC GENE ADMINISTRATION |
US7780882B2 (en) * | 1999-02-22 | 2010-08-24 | Georgetown University | Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
WO2001082899A2 (en) * | 2000-05-03 | 2001-11-08 | Mbt Munich Biotechnology Ag | Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
WO2003084386A2 (en) * | 2002-04-03 | 2003-10-16 | See Jackie R | Methods for ultrasonic imaging and treating diseased tissues |
US20040241088A1 (en) * | 2003-01-28 | 2004-12-02 | Georgetown University | Method for evaluating the efficacy of certain cancer treatments |
CN103251562B (en) * | 2003-06-04 | 2016-04-27 | 乔治敦大学 | The stability of flexible liposomes complex and the method for storage life |
EP1648299A4 (en) * | 2003-07-09 | 2008-10-22 | California Pacific Med Center | Remote detection of substance delivery to cells |
JP2005170807A (en) * | 2003-12-09 | 2005-06-30 | Fuji Photo Film Co Ltd | Liposome containing antibody |
-
2006
- 2006-10-20 AU AU2006304790A patent/AU2006304790B2/en not_active Ceased
- 2006-10-20 JP JP2008536843A patent/JP5478886B2/en not_active Expired - Fee Related
- 2006-10-20 CN CN2006800465731A patent/CN101351225B/en not_active Expired - Fee Related
- 2006-10-20 KR KR1020087011910A patent/KR20080064169A/en not_active Application Discontinuation
- 2006-10-20 WO PCT/US2006/041139 patent/WO2007047981A2/en active Application Filing
- 2006-10-20 CA CA2638899A patent/CA2638899C/en not_active Expired - Fee Related
-
2008
- 2008-04-10 IL IL190773A patent/IL190773A/en active IP Right Grant
-
2009
- 2009-07-20 HK HK09106582.2A patent/HK1129063A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101351225B (en) | 2013-09-25 |
IL190773A0 (en) | 2008-11-03 |
WO2007047981A2 (en) | 2007-04-26 |
CN101351225A (en) | 2009-01-21 |
KR20080064169A (en) | 2008-07-08 |
WO2007047981A3 (en) | 2007-10-25 |
JP5478886B2 (en) | 2014-04-23 |
AU2006304790B2 (en) | 2013-06-27 |
CA2638899A1 (en) | 2007-04-26 |
CA2638899C (en) | 2016-01-05 |
AU2006304790A1 (en) | 2007-04-26 |
JP2009512712A (en) | 2009-03-26 |
IL190773A (en) | 2012-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1129063A1 (en) | Tumor-targeted nanodelivery systems to improve early mri detection of cancer | |
GB0600682D0 (en) | Improvements to doppler radar systems | |
EP2032594A4 (en) | Glycyrrhetinic acid derivatives | |
PL2210246T3 (en) | Proximity detection system | |
IL198062A0 (en) | Improvements relating to the detection of patterns | |
ZA201001878B (en) | Improved detection of mage-a-expression | |
IL176240A0 (en) | Methods and systems using relative sensing to locate targets | |
SI1858929T1 (en) | Diagnosis of prostate cancer | |
EP2147298A4 (en) | Detection of cancer markers | |
IL198976A0 (en) | Companion diagnostic assays for cancer therapy | |
EP2114432A4 (en) | Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric isf35 | |
GB0820309D0 (en) | Detection of cancer | |
EP2119018A4 (en) | Techniques to deterministically reduce signal interference | |
GB0525541D0 (en) | Detection of antibodies | |
HK1133161A1 (en) | Piece of luggage | |
EP2212874A4 (en) | Tracker and localizer of semi-trailers | |
HK1110655A1 (en) | Diagnostic signal processor | |
GB0820899D0 (en) | Early detection of sepsis | |
EP1856645A4 (en) | Targets for detection of ischemia | |
ZA200710929B (en) | Detection of hepatotoxic cyanobacteria | |
GB0709044D0 (en) | Signal detection | |
GB0515325D0 (en) | Improvements relating to the detection of lower limb disease | |
GB2444777B (en) | Detection of radiation | |
GB0604231D0 (en) | Cancer detection system | |
IL190949A0 (en) | Jn vivo detection of apoptosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171020 |